These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 24044714

  • 1. Intra-arterial chemotherapy for group C retinoblastoma with adjacent high-flow infantile hemangioma.
    Yonekawa Y, Orbach DB, Trief D, Shah AS, Vanderveen DK.
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(5):490-2. PubMed ID: 24044714
    [Abstract] [Full Text] [Related]

  • 2. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N, Català-Mora J.
    J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
    [No Abstract] [Full Text] [Related]

  • 3. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
    Hutchinson A, Kaliki S, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2012 Mar 27; 49 Online():e15-8. PubMed ID: 22443587
    [Abstract] [Full Text] [Related]

  • 4. INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA IN A 2-MONTH-OLD INFANT.
    Magan T, Khoo CT, Jabbour PM, Shields CL.
    Retin Cases Brief Rep; 2012 Mar 27; 11(1):24-26. PubMed ID: 26756523
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Complete regression of retinoblastoma following intra-arterial chemotherapy.
    Ni N, Shields CL, Bianciotto CG, Jabbour PM, Rosenwasser RH, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2011 Jun 07; 48 Online():e23-5. PubMed ID: 21634361
    [Abstract] [Full Text] [Related]

  • 7. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.
    Arch Ophthalmol; 2011 Nov 07; 129(11):1399-406. PubMed ID: 21670328
    [Abstract] [Full Text] [Related]

  • 8. Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.
    Materin MA, Kuzmik GA, Jubinsky PT, Minja FJ, Asnes JD, Bulsara KR.
    J Neurointerv Surg; 2013 Nov 07; 5(6):e42. PubMed ID: 23188789
    [Abstract] [Full Text] [Related]

  • 9. Superselective intraophthalmic artery chemotherapy: what we do not know.
    Wilson MW, Haik BG, Dyer MA.
    Arch Ophthalmol; 2011 Nov 07; 129(11):1490-1. PubMed ID: 22084220
    [No Abstract] [Full Text] [Related]

  • 10. Hemorrhage as a sign of treatment failure after intra-arterial chemotherapy in retinoblastoma.
    Silva RA, Dubovy SR, Hess D, Stratton R, Murray TG.
    J AAPOS; 2015 Jun 07; 19(3):268-70. PubMed ID: 25907829
    [Abstract] [Full Text] [Related]

  • 11. Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.
    Sarici A, Kizilkilic O, Celkan T, Gode S.
    JAMA Ophthalmol; 2013 Jun 07; 131(6):801-2. PubMed ID: 23764710
    [No Abstract] [Full Text] [Related]

  • 12. Ocular dysmotility after intra-arterial chemotherapy for retinoblastoma.
    Lambert NG, Winegar BA, Feola GP, Ramasubramanian A.
    J AAPOS; 2015 Dec 07; 19(6):574-7. PubMed ID: 26691048
    [Abstract] [Full Text] [Related]

  • 13. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
    Aziz HA, Boutrid H, Murray TG, Berrocal A, Wolfe SQ, Pina Y, Dorfman M, Moftakhar R, Fernandes CE, Reichbach J, Aziz-Sultan MA.
    Retina; 2010 Apr 07; 30(4 Suppl):S63-5. PubMed ID: 20224464
    [Abstract] [Full Text] [Related]

  • 14. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
    Chao A, Kao LY, Liu L, Wang NK.
    BMC Ophthalmol; 2016 Mar 15; 16():27. PubMed ID: 26975871
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma.
    Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG, Shields C.
    J Neurosurg Pediatr; 2012 Sep 15; 10(3):175-81. PubMed ID: 22793160
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
    Tuncer S, Sencer S, Kebudi R, Tanyıldız B, Cebeci Z, Aydın K.
    Acta Ophthalmol; 2016 Nov 15; 94(7):e644-e651. PubMed ID: 27214798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.